chr2-32947376-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_206943.4(LTBP1):c.52G>T(p.Ala18Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000293 in 1,365,066 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_206943.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LTBP1 | NM_206943.4 | c.52G>T | p.Ala18Ser | missense_variant | 1/34 | ENST00000404816.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LTBP1 | ENST00000404816.7 | c.52G>T | p.Ala18Ser | missense_variant | 1/34 | 5 | NM_206943.4 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151656Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000343 AC: 1AN: 29186Hom.: 0 AF XY: 0.0000575 AC XY: 1AN XY: 17384
GnomAD4 exome AF: 0.00000165 AC: 2AN: 1213302Hom.: 0 Cov.: 34 AF XY: 0.00000337 AC XY: 2AN XY: 593016
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151764Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74190
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.52G>T (p.A18S) alteration is located in exon 1 (coding exon 1) of the LTBP1 gene. This alteration results from a G to T substitution at nucleotide position 52, causing the alanine (A) at amino acid position 18 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at